Showing results (31-40 of 131) with videos related to
Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1993
Catheter-related Fusarium solani fungemia and pulmonary infection in a patient with leukemia in remissionL K Ammari, J M Puck, K L McGowanThe Biochemical Journal|March 15, 1989
The diacylglycerol analogue, 1,2-sn-dioctanoylglycerol, induces an increase in cytosolic free Ca2+ and cytosolic acidification of T lymphocytes through a protein kinase C-independent processR Ebanks, C Roifman, A Mellors, et al.Acta Haematologica|April 15, 1999
Retroviral-mediated transfer and expression of the common gamma chain into human hematopoietic progenitorsF Candotti, M Onodera, R A Knazek, et al.La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|March 1, 1991
[Cellular and molecular therapy in severe combined immunodeficiencies]F Porta, F Candotti, A Arrighini, et al.Journal of Clinical Immunology|January 7, 1998
Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiencyJ J O'Shea, L D Notarangelo, J A Johnston, et al.Genomics|October 1, 1991
The gene encoding human TFE3, a transcription factor that binds the immunoglobulin heavy-chain enhancer, maps to Xp11.22P S Henthorn, C C Stewart, T Kadesch, et al.Gene Therapy|November 3, 1998
Characterization of an MDR1 retroviral bicistronic vector for correction of X-linked severe combined immunodeficiencyS E Kleiman, I Pastan, J M Puck, et al.The Journal of Clinical Investigation|February 1, 1995
Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiencyJ M Puck, A E Pepper, P M Bédard, et al.Acta Haematologica|April 15, 1999
Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trialsM Onodera, D M Nelson, Y Sakiyama, et al.Cellular Immunology|March 1, 1983
Antigen presentation to human T lymphocytes. II. Requirements for Mac-120+ macrophages and responsiveness to interleukin 2S L Abramson, M F Brown, J M Puck, et al.Pageof 14